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The fear circuitry orchestrates defense mechanisms in response to environmental
threats. This circuitry is evolutionarily crucial for survival, but its dysregulation is
thought to play a major role in the pathophysiology of psychiatric conditions in
humans. The amygdala is a key player in the processing of fear. This brain area is
prominently modulated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
The 5-HT input to the amygdala has drawn particular interest because genetic and
pharmacological alterations of the 5-HT transporter (5-HTT) affect amygdala activation
in response to emotional stimuli. Nonetheless, the impact of 5-HT on fear processing
remains poorly understood.The aim of this review is to elucidate the physiological role of
5-HT in fear learning via its action on the neuronal circuits of the amygdala. Since 5-HT
release increases in the basolateral amygdala (BLA) during both fear memory acquisition
and expression, we examine whether and how 5-HT neurons encode aversive stimuli
and aversive cues. Next, we describe pharmacological and genetic alterations of 5-HT
neurotransmission that, in both rodents and humans, lead to altered fear learning. To
explore the mechanisms through which 5-HT could modulate conditioned fear, we focus
on the rodent BLA. We propose that a circuit-based approach taking into account the
localization of specific 5-HT receptors on neurochemically-defined neurons in the BLA
may be essential to decipher the role of 5-HT in emotional behavior. In keeping with a
5-HT control of fear learning, we review electrophysiological data suggesting that 5-HT
regulates synaptic plasticity, spike synchrony and theta oscillations in the BLA via actions
on different subcellular compartments of principal neurons and distinct GABAergic
interneuron populations. Finally, we discuss how recently developed optogenetic
tools combined with electrophysiological recordings and behavior could progress the
knowledge of the mechanisms underlying 5-HT modulation of fear learning via action on
amygdala circuits. Such advancement could pave the way for a deeper understanding
of 5-HT in emotional behavior in both health and disease.
Keywords: serotonin transporter gene, serotonin, mouse models, amygdala, interneurons, SSRI antidepressants,
fear
INTRODUCTION
The amygdala, an almond-shaped structure in the medial temporal lobe, is thought to
be critical for emotional processing (Klüver and Bucy, 1938; Weiskrantz, 1956; LeDoux,
2000). In recent years, the dissection of the amygdala microcircuits controlling conditioned
fear has provided fundamental insights into the neurobiology of emotion (for review,
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see Duvarci and Pare, 2014; Tovote et al., 2015). Dysregulation
of amygdala circuitry is thought to contribute to symptoms
in many psychiatric disorders including depression (Sheline
et al., 2001; Victor et al., 2010), post-traumatic stress disorder
(Rauch et al., 2000; Protopopescu et al., 2005), social phobia
(Tillfors et al., 2001; Furmark et al., 2002) and other phobias
(Ahs et al., 2009). Therefore, understanding amygdala circuitry
may ultimately lead to improved therapies for psychiatric
disorders.
In mammals, the amygdala is densely innervated by fibers
releasing 5-hydroxytryptamine (5-HT), which arise from the
midbrain raphe nuclei (Parent et al., 1981). The 5-HT system
appears to be crucial for myriad brain functions, including
sleep, appetite, sensory processing, motor activity, cognition and
emotion. In particular, the 5-HT system has long been implicated
in the regulation of aversive emotions such as fear and anxiety
(Deakin and Graeff, 1991; Lowry et al., 2005). Two aspects
suggest that 5-HT may influence emotional processing, at least
in part, via modulation of amygdala function. First, drugs that
block the re-uptake of 5-HT (e.g., selective serotonin reuptake
inhibitors, SSRIs), the first-line treatment for depression and
anxiety (Preskorn et al., 2004), affect amygdala activation to
emotional stimuli (Bigos et al., 2008; Murphy et al., 2009;
Godlewska et al., 2012). Second, genetic variations in the 5-HT
transporter (5-HTT) influence amygdala activation to aversive
stimuli, as well as expression of anxiety-related personality traits
and risk for affective disorders (Lesch et al., 1996; Hariri et al.,
2002).
Notably, not all studies are consistent with the involvement
of human 5-HTT gene variations in fear memory processing
(Murphy et al., 2013), which has cast doubt on the link between
5-HT neurotransmission, amygdala and fear. However, human
findings are complicated by environmental and demographic
factors. In addition, the techniques available to study human
brain function, such as non-invasive functional neuroimaging,
lack the necessary spatial and temporal resolution to reveal
how 5-HT impacts upon specific amygdala microcircuits.
Here we review molecular, anatomical, electrophysiological and
behavioral data to elucidate the physiological role of 5-HT on
amygdala function and fear learning. We focus on the rodent
basolateral amygdala (BLA) because this nucleus receives a
dense projection from 5-HT neurons of the dorsal raphe
nuclei (DRN) and is well understood functionally. We propose
that physiologically released 5-HT in the BLA shapes fear
learning via action on defined cell types and control of synaptic
plasticity.
DO DRN 5-HT NEURONS ENCODE
AVERSIVE SIGNALS?
To understand the role of 5-HT in fear learning, it is crucial
to determine whether aversive stimuli and aversive cues lead to
a modulation of 5-HT neurons’ firing and, as a result, to an
alteration of 5-HT levels in the amygdala. The main source of
5-HT modulation of the amygdala is the DRN in the midbrain.
Although it is not clear whether DRN neurons release 5-HT
even at low firing rates or only above a certain threshold, it
is generally believed that increased firing rates of DRN 5-HT
neurons translate into elevated 5-HT levels in target forebrain
areas, including the BLA. In line with this assumption, the firing
rates of DRN 5-HT neurons and forebrain 5-HT concentrations
are high during wakefulness and low during sleep (Portas et al.,
1998; Sakai, 2011).
In the laboratory, fear learning can be assessed with a high
level of control through Pavlovian fear conditioning, which
involves pairing a conditioned stimulus (CS; e.g., an auditory
tone) with an unconditioned stimulus (US; e.g., an electric
shock). The acquisition of an associative fear memory during this
training session causes the presentation of the CS only during the
test (or fear retrieval) session to elicit fear responses. Although
5-HT neurons have been hypothesized to encode aversive cues
and to generate aversive prediction error signals (Deakin and
Graeff, 1991; Daw et al., 2002; Dayan andHuys, 2009), recordings
from identified 5-HT neurons during fear conditioning have not
been reported.
Nonetheless, some DRN 5-HT neurons display phasic
increases in firing rates at the onset of footshocks in anesthetized
rats (Schweimer and Ungless, 2010) and following punishment
(air-puff to the eye) in awake, head-fixed mice (Cohen et al.,
2015). In keeping with this, an increased c-Fos expression
in DRN 5-HT neurons was observed following presentation
of noxious stimuli (Grahn et al., 1999; Takase et al., 2004,
2005). Conversely, imaging experiments from the DRN of
freely moving mice have shown that 5-HT cells do not display
significant calcium transients following footshock presentations
(Li et al., 2016).
In addition to noxious stimuli per se, presentation of a
CS previously paired with a shock has also been shown to
promote c-Fos expression in DRN 5-HT cells (Spannuth et al.,
2011). However, Cohen et al. (2015) found that an odor CS
that predicted punishment did not produce phasic excitation
of 5-HT neurons in head-fixed mice. Future investigations
are needed to comprehend the discrepancies between these
studies. Since the DRN 5-HT neurons are topographically
organized according to the areas they innervate (Jacobs et al.,
1978; Imai et al., 1986), some inconsistency might reside in
the portion of the DRN where neurons were recorded or
imaged.
Despite these controversies, microdialysis studies suggest
that both CS and US presentations are capable of enhancing
5-HT release in the BLA, with increased 5-HT in response
to inescapable shocks (Amat et al., 1998), psychological stress
(Kawahara et al., 1993) and fear memory retrieval (Zanoveli
et al., 2009). Interestingly, these rises in 5-HT levels are slow
and long-lasting (peaking at ∼30 min from CS/US presentation;
Yokoyama et al., 2005; Zanoveli et al., 2009). Hence, BLA-
projecting DRN 5-HT neurons might signal aversion not
via phasic increases in firing rate upon CS/US presentation,
but rather by progressive enhancement in their frequency of
discharge.
In summary, there is evidence that DRN 5-HT neurons
modulate BLA circuits during fear conditioning by enhancing
the release of 5-HT. However, there is mixed evidence about
the phasic activation of 5-HT neurons by unconditioned and
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conditioned aversive cues. Recordings from identified DRN
5-HT neurons during different phases of fear conditioning
are needed to elucidate their physiology in this paradigm.
Additionally, the relationship between DRN neurons’
firing rates and BLA 5-HT release should be directly
investigated.
IMPACT OF GENETIC VARIATIONS OF THE
5-HTT ON THE BLA AND FEAR LEARNING
After reviewing the evidence that 5-HT levels increase in
the BLA following aversive stimuli, we now ask whether
genetic variation in the 5-HT system affects fear learning.
The neurotransmission of 5-HT is tightly regulated by the
5-HTT, a transmembrane protein that clears 5-HT from the
extracellular space and therefore controls the duration and extent
of 5-HT neurotransmission (Blakely et al., 1994; Torres and
Amara, 2007). In humans, a 44 base pair insertion/deletion
polymorphism in the 5-HTT gene promoter region (5-HTT
gene linked polymorphic region or 5-HTTLPR) gives rise
to long (L) and short (S) allele variants. The S allele is
associated with reduced transcriptional efficacy, and hence lower
transporter expression, leading to reduced 5-HT re-uptake and
high extracellular 5-HT levels (Greenberg et al., 1999). This
variation has been associated with greater risk for anxiety-related
traits (Lesch et al., 1996) and post-traumatic stress disorder
(Lee et al., 2005). Furthermore, S carriers show heightened fear
learning (Garpenstrand et al., 2001; Brocke et al., 2006; Lonsdorf
et al., 2009) and increased depression/anxiety susceptibility
(Lesch et al., 1996), particularly when combined with adverse
environmental factors (Caspi et al., 2003; Uher and McGuffin,
2010). Notably, the 5-HTTLPR is also associated with functional
alterations in amygdala activity. Specifically, compared to LL
homozygotes, S carriers exhibit greater amygdala activation to
fearful faces (Hariri et al., 2002, 2005) and reduced amygdala-
medial prefrontal cortex (mPFC) connectivity (Canli et al.,
2005; Pezawas et al., 2005). However, the association between
5-HTTLPR genotype and amygdala reactivity in humans remains
controversial and the effect size is small (Murphy et al.,
2013).
Mice with genetically modified 5-HTT expression offer a
more controlled model to investigate the impact of 5-HTT
variation on fear learning and amygdala function. 5-HTT
knock-out (5-HTTKO) mice display higher extracellular
5-HT levels (Mathews et al., 2004; Jennings et al., 2010) and
impaired recall of fear extinction compared to wild-type
littermate controls (Wellman et al., 2007). Furthermore,
5-HTTKO mice exhibit abnormal dendritic spine density
of BLA principal neurons (PNs) (Wellman et al., 2007).
Conversely, 5-HTT overexpressing (5-HTTOE) mice have
lower extracellular 5-HT levels than WT littermate controls
(Jennings et al., 2006, 2010) and exhibit impaired fear
learning (Barkus et al., 2014; Line et al., 2014; Bocchio
et al., 2015; McHugh et al., 2015; Figure 1A). Collectively,
these findings support a positive correlation between
5-HT levels and fear learning, potentially, at least in part,
via the action of physiologically released 5-HT on BLA
circuits.
However, it should be kept in mind that constitutive genetic
alteration of 5-HTT expression will likely change 5-HT signaling
during brain development. It is therefore unclear whether effects
on fear learning originate from: (1) 5-HT neurotransmission in
adulthood; or (2) altered neuronal circuit development; or both
of these factors.
Supporting the developmental account, several lines of
evidence suggest that life-long changes in 5-HTT expression
result in compensatory changes in 5-HT receptor expression
and function in rodents. Namely, altered 5-HT1A (Holmes
et al., 2003) and 5-HT2A (Li et al., 2003; Jennings et al.,
2008; Bocchio et al., 2015) functions have been reported
in both 5-HTTKO and 5-HTTOE mice. Furthermore,
interfering with 5-HT neurotransmission during development
alters emotional behavior in adulthood (Gross et al., 2002;
Ansorge et al., 2004). Thus, studies with temporally precise
and reversible manipulations of 5-HT neurotransmission
are imperative to verify that 5-HT levels at the time
of behavioral testing are responsible for the effects on
fear learning.
Impact of 5-HT Neurotransmission
Manipulation on Fear Learning
One approach to confirm the causal link between high
extracellular 5-HT levels and fear learning is the pharmacological
blockade of the 5-HTT with SSRIs. This intervention raises
extracellular 5-HT levels reversibly, in principle conferring
higher temporal resolution than genetic variations to evaluate
changes in behavior. Notably, acute and chronic administration
of SSRIs appears to produce different effects.
Acute citalopram treatment increases 5-HT levels in
the amygdala (Bosker et al., 2001). In humans, citalopram
administration (20 mg) 2–3 h before acquisition increases
fear-potentiated startle (Browning et al., 2007; Grillon et al.,
2007). In rats, acute citalopram (intraperitoneal injection,
10 mg/kg, equivalent to 25 mg in humans according to plasma
drug levels) before either auditory fear conditioning or fear
expression increases freezing responses (Burghardt et al., 2004,
2007). Together, these data suggest that transitory increases
in extracellular 5-HT levels facilitate both the acquisition and
the expression of conditioned fear in a cued fear conditioning
paradigm. In contrast, chronic citalopram administration in
humans (10 mg/day for 2 days followed by 20 mg/day for
12 days) does not affect fear-potentiated startle (Grillon et al.,
2009). In rats, chronic citalopram administration (10 mg/kg
for 21 days) before (and during) fear acquisition decreases
freezing during fear expression (Burghardt et al., 2004).
This suggests that acute and chronic SSRI treatments have
markedly different effects on fear learning, in agreement with
their dichotomous effects on emotionality (acute treatment
increases anxiety, whereas chronic administration has stronger
antidepressant actions). Many attempts have been made to
explain SSRI acute and chronic effects on the healthy and
pathological brain (e.g., Harmer and Cowen, 2013), but a
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FIGURE 1 | Reduced basolateral amygdala (BLA) theta oscillations and recruitment of parvalbumin-expressing (PV) Interneurons (INs) in
5-hydroxytryptamine transporter over expressing (5-HTTOE) mice. (A) Wild-type mice (WT) exhibit significantly increased freezing during conditioned auditory
tone conditioned stimulus (CS), whereas 5-HTTOE mice do not. (B) Representative spectrograms showing auditory cue-evoked oscillations in the BLA of a WT and
5-HTTOE mouse. CS+ presentation evokes a higher increase in oscillations in the theta band (5–12 Hz) in the BLA of the WT compared to the 5-HTTOE mouse.
(C) Representative BLA PV+ neuron from a WT mouse that was activated by fear memory retrieval (c-Fos immunopositive). (D) BLA PV INs of WT mice are activated
significantly more by fear memory retrieval than PV INs of 5-HTTOE mice. (E) BLA PV INs of WT mice display a much stronger depolarization than 5-HTTOE PV INs
when 5-HT (50 µM) is bath applied. ∗p < 0.05. (A,B) Adapted from Barkus et al. (2014). (C–E) Adapted from Bocchio et al. (2015).
conclusive account is still lacking. The discrepant action on
fear memory retrieval could be partially explained by the fact
that chronic SSRI treatment causes whole brain adaptive to
changes to 5-HT receptors (Klimek et al., 1994; El Mansari
et al., 2005), as well as downregulation of the NR2B subunit
of NMDA receptors in the BLA (Burghardt et al., 2004). More
studies are needed to provide a mechanistic understanding
of the impact of short-term vs. long-term changes in 5-HTT
function.
Whole brain 5-HT levels can be manipulated also through
dietary depletion of the 5-HT precursor tryptophan. In humans,
this treatment decreases the recognition of fearful faces (Harmer
et al., 2003) and reduces autonomic responses to cues indicating
imminent aversive stimuli (Hindi Attar et al., 2012). Thus, based
on SSRI administration and dietary tryptophan depletion studies,
5-HT levels seem to contribute to fear memory acquisition
and expression. This contribution is likely to occur, at least
in part, via modulation of amygdala circuits, because the
amygdala is a crucial structure for the encoding of cued
conditioned fear. Nevertheless, SSRI treatment results in changes
in 5-HT levels in the whole brain. This indicates that SSRIs
might modulate fear learning not only via altered 5-HT
neurotransmission in the BLA, but also via concomitant action
on other brain regions involved in defensive behavior, such as
the hippocampus (HPC), the medial prefrontal cortex (mPFC)
and the periaqueductal gray.
To confirm the impact of 5-HT on the amygdala circuits,
selective lesions of 5-HT terminals can be performed in rodents
using the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT;
Baumgarten and Björklund, 1976). Notably, lesion of 5-HT
fibers in the BLA reduces freezing to both tone CSs (during
acquisition and retrieval) and the training context (during
retrieval; Izumi et al., 2012; Johnson et al., 2015). However,
one study has reported enhanced fear-potentiated startle in rats
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with 5,7-DHT lesions restricted to the lateral amygdala (LA;
Tran et al., 2013).
Manipulation of endogenous 5-HT release can now be
achieved in rodents with high spatial and temporal selectivity
using optogenetics. Recently, Baratta et al. (2015) have shown
that optical inhibition of DRN 5-HT axon terminals in the BLA
during CS-US pairings (or unpaired USs) during the acquisition
phase impaired fear memory retrieval. However, this deficit
occurred only when mice were subjected to 2 days of stress prior
to fear conditioning, but not in unstressed mice.
Taken together, the data presented in this section suggest that
5-HT neurotransmission in the BLA is involved in the acquisition
(and probably the expression) of cued conditioned fear. It
remains to be confirmed whether the optogenetic activation of
DRN 5-HT axons in the BLA could alter fear memory acquisition
and expression, thereby demonstrating not only the necessity but
also the sufficiency of BLA 5-HT. Undoubtedly, the link between
5-HT-dependent stress and fear learning also deserves further
attention.
BLA CIRCUIT DYNAMICS UNDERLYING
FEAR LEARNING
To understand how BLA 5-HT neurotransmission influences
fear learning, it is important to use circuit-based approaches
and determine how 5-HT modulates BLA microcircuits. In the
last decades, research in rodents has provided unprecedented
knowledge about the neurobiological mechanisms underlying
fear conditioning.
A simple circuit model of fear learning (Sigurdsson et al.,
2007) suggests that information about tone and shock is relayed,
via glutamatergic fibers, from sensory areas of thalamus and
cortex to PNs lateral (LA) subdivision of the BLA. Prior to
fear conditioning these inputs are weak, but pairing the tone
and shock together strengthens CS-specific inputs to specific
ensembles of PNs via long-term potentiation (LTP; Romanski
et al., 1993; McKernan and Shinnick-Gallagher, 1997; Rogan
et al., 1997; Goosens et al., 2003; Collins and Paré, 2000;
Nabavi et al., 2014). The LA projects to the basal (BA)
subdivision of the BLA, and both LA and BA project to the
central nucleus of the amygdala (CeA), in addition to other
brain regions. The CeA contains mostly GABAergic neurons
that innervate several brain stem nuclei to promote defensive
responses (Veening et al., 1984; Ciocchi et al., 2010; Penzo
et al., 2014). For example, CeA projections to the nucleus
reticularis pontis caudalis mediate acoustic startle reflexes
(Davis et al., 1982), and CeA projections to the periaqueductal
gray region mediate freezing responses (LeDoux et al., 1988;
Amorapanth et al., 1999; Penzo et al., 2014). Thus, LTP at
synapses between CS-relaying axons and LA PNs following fear
conditioning is thought to contribute to freezing responses at
subsequent CS presentations via action of BLA PNs on CeA
neurons.
This circuit model places significant emphasis on
glutamatergic BLA PNs, pyramidal-like projection neurons
with spiny dendrites that account for ∼80% of BLA cells
(McDonald, 1982) and which occupy a key position between
sensory input and behavioral output. However, it is important
to keep in mind that their activity is tightly coordinated by
the release of GABA from BLA interneurons (INs), which are
characterized by mostly aspiny dendrites and widely branching
local axons (McDonald, 1982; Millhouse and DeOlmos, 1983).
BLA INs provide feedforward inhibition to LA PNs and act
as gatekeepers of synaptic plasticity because depression of
feedforward inhibition is necessary to induce LTP at BLA PNs
(Watanabe et al., 1995; Bissière et al., 2003; Tully et al., 2007;
Morozov et al., 2011).
BLA INs are heterogenous and can be classified according
to their neurochemical profile, and in particular the expression
of specific calcium binding proteins or neuropeptides (Table 1,
Figure 2A; for review Capogna, 2014). Defined IN types
control the inhibition of BLA PNs subcellular compartments,
altering PN integration of excitatory inputs and modulating
PN spike timing. For example, during US presentation,
both parvalbumin-expressing (PV) and somatostatin-expressing
(SOM) INs are inhibited, leading to robust somatic and dendritic
disinhibition of PNs (Wolff et al., 2014). In contrast, presentation
of the CS produces excitation of PV INs, which in turn
inhibit SOM INs, leading to disinhibition on PN dendrites,
with a facilitation of excitatory input integration by PNs
(Wolff et al., 2014).
As discussed in the next sections, 5-HT regulates the
excitability and the integration of excitatory inputs of BLA PNs,
and also their inhibition by GABAergic INs. Through these
actions on BLA circuits, 5-HT can shape BLA output to the CeA
and ultimately, the physiological and behavioral manifestations
of fear.
5-HT INNERVATION OF BLA NEURONS
5-HT projections to the BLA arise predominantly frommidbrain
DRN neurons (Jacobs et al., 1978; Abrams et al., 2004), with
only very sparse innervation from the median raphe nuclei
(Jacobs et al., 1978; Vertes et al., 1999). 5-HT projections to
the amygdaloid complex have been described in several ways,
including the use of immunohistochemical labeling of either
5-HT (Steinbusch, 1981; Muller et al., 2007) or the 5-HTT (Sur
et al., 1996). Both approaches reveal similar 5-HT innervation
patterns in the amygdala of rodents. Typically, 5-HT axons
project strongly to the BA, moderately to LA, basomedial
and centromedial nuclei and only weakly to the centrolateral
nucleus (Figure 3; Steinbusch, 1981; Sur et al., 1996; Muller
et al., 2007). In the BLA, they innervate both PNs and INs
(Muller et al., 2007).
To understand the effects of 5-HT on BLA microcircuits and
fear learning, it is important to remember that LA and BA are not
the same: they receive different inputs, project to different areas
(reviewed in Sah et al., 2003; Duvarci and Pare, 2014), and are
likely to be differentially modulated by 5-HT. It is also crucial to
consider the localization of specific 5-HT receptor subtypes and
defined cell types within the BLA microcircuits. For instance, a
5-HT receptor leading to membrane depolarization will have a
profoundly different effect on network processing if it is located
on a PN compared to an IN and vice versa.
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TABLE 1 | Features and 5-HT receptor expression of main BLA GABAergic classes.
Marker % of Known cell Known Activity 5-HT Functional
BLA INs types postsynaptic during fear receptor effects
targets in BLA conditioning expression of 5-HT
PV
(high overlap with CB)
∼50% Basket;
Axo-axonic;
AStria projecting
PN; PV; SOM
(perisomatic region)
Inhibited during US,
excited during
CS (on average)
5-HT2A Slow depolarization
SOM
(high overlap with CB)
11–18% Dendrite-projecting
INs; Long-range
projection neurons
PN (mostly distal
dendrites, few
proximal dendrites
and somata);
PV; VIP; SOM
Inhibited during US
and CS (on average)
5-HT2A
(only 30%,
to be verified)
Slow depolarization?
Hyperpolarization
via GABA release
from PV INs?
VIP
(high overlap with CR,
some overlap with CCK)
∼10% Small CCK;
VIP (CCK-negative)
PN (soma and
distal dendrites),
CB, VIP
Unknown Unknown Unknown
5-HT3A (CCK-negative) 6–12% Unknown Unknown Unknown 5-HT3A Fast depolarization
NPY (high overlap with
CB and SOM)
3–6% Neurogliaform;
Long-range
projection neurons
PN (mostly proximal
dendrites, but also
somata)
Unknown 5-HT1A; 5-HT2C Slow hyperpolarization
(1A) and/or
slow depolarization (2C)?
CCK/CB1R (some
overlap with CB)
∼4% Large CCK PN, CCK
(perisomatic region)
Unknown 5-HT3A
(only 8–16%)
Fast depolarization?
Abbreviations: CB, calbindin; CB1R, cannabinoid 1 receptor; CCK, cholecystokinin; NPY, neuropeptide Y; PN, principal neuron; PV, parvalbumin; SOM, somatostatin; VIP,
vasoactive intestinal peptide; CS, conditioned stimulus; US, unconditioned stimulus.
Glutamatergic Principal Neurons
Muller et al. (2007) found that 5-HT terminals form
synaptic contacts with the distal dendrites of PNs. In the
LA, both autoradiographic and in situ hybridization studies
indicate high expression of 5-HT2C receptors (Li et al.,
2003; Greenwood et al., 2012). As more than 80% of LA
neurons are PNs, this is consistent with the 5-HT2C-
mediated depolarizing effect of exogenous 5-HT found
in LA PNs (Yamamoto et al., 2014). In contrast, in the
BA McDonald and Mascagni (2007) reported labeling of
PN dendrites obtained with two out of three 5-HT2A
antibodies, while another antibody stained only PNs of the
dorsolateral division of the LA. However, BA PNs are not
depolarized by 5-HT2 agonists (Yamamoto et al., 2014). Thus,
5-HT2A receptors may not alter the membrane excitability
in PNs somatically, but rather modulate the integration of
dendritic inputs. Consistent with this idea, Chen et al. (2003)
found that 5-HT2 activation enhanced NMDA receptor-
mediated synaptic plasticity in putative PNs. In addition,
a minority of PNs are directly hyperpolarized by 5-HT
(Rainnie, 1999; Bocchio et al., 2015). This hyperpolarization
could occur via activation of 5-HT1A receptors, which
have been shown to be densely expressed in the BLA
(Saha et al., 2010).
GABAergic Interneurons
5-HT fibers target various IN classes in the BLA (Figure 2B;
Muller et al., 2007; Bonn et al., 2013). Although PNs appear to
be oppositely modulated by 5-HT in LA and BA, it is not clear
yet whether IN populations express the same 5-HT receptors in
both nuclei. Thus, most of the data reviewed in this section refer
generally to the BLA, with no distinction between LA and BA.
The PV INs are believed to control fear learning via their
regulation of PN spike timing and synchrony (Woodruff and
Sah, 2007; Wolff et al., 2014) and their inhibition of SOM INs
(Wolff et al., 2014). PV INs are innervated by 5-HT axons in
the perisomatic region. This innervation is both synaptic and
non-synaptic (Muller et al., 2007). In both LA and BA, PV
INs express 5-HT2A receptors (McDonald and Mascagni, 2007;
Jiang et al., 2009), which mediate membrane depolarization
(Bocchio et al., 2015; Table 1 and Figure 1). Notably, mice
genetically-engineered to overexpress the 5-HTT (5-HTTOE
mice) have reduced 5-HT2A-mediated depolarization of PV
INs (Bocchio et al., 2015; Figure 1D). 5-HTTOE mice exhibit
low anxiety and impaired fear learning (Figure 1A; Jennings
et al., 2006; Barkus et al., 2014; Line et al., 2014; Bocchio
et al., 2015; McHugh et al., 2015), suggesting a link between
reduced 5-HT2A receptor activation on PV INs and lower
levels of anxiety/fear. In support of this, chronic citalopram
administration, which is a clinically effective anxiolytic, also
decreases forebrain 5-HT2A receptor binding (Günther et al.,
2008).
The SOM INs, thought to contribute to fear learning via
their dendritic inhibition of PNs (Wolff et al., 2014), are also
targeted by 5-HT fibers (Muller et al., 2007). McDonald and
Mascagni (2007) obtained labeling of ∼30% of SOM INs using
one out of three 5-HT2A antibodies. Thus, a minority of
these neurons might also be depolarized via 5-HT2A signaling,
but this has not been tested so far. Approximately 30% of
SOM+ neurons co-express neuropeptide Y (NPY; McDonald,
1989). These NPY+ neurons receive dense 5-HT innervation
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FIGURE 2 | BLA neurons connectivity, 5-HT innervation and 5-HT receptor expression. (A) Connectivity between BLA principal neurons (PNs) and
interneuron (IN) populations in rodents. Parvalbumin (PV) INs target the perisomatic region of PNs (soma, proximal dendrites, axon initial segment), but also inhibit
somatostatin-expressing (SOM) INs, disinhibiting PNs distal dendrites. Vasoactive intestinal peptide (VIP) INs inhibit PN soma and proximal dendrites. As they have
been shown to inhibit high numbers of Calbindin (CB)-expressing (CB+) INs, and the majority of CB+ INs are either PV or SOM, VIP INs could target PV and/or SOM
INs, disinhibiting specific PN subcellular compartments, but this has not been demonstrated. The VIP-negative CB1R+ population of Cholecystokinin (CCK) INs
(large CCK) target PN perisomatic region. Although it is likely that CCK-negative 5-HT3A+ INs contact PNs, this has not been shown experimentally. A subset of
neuropeptide Y (NPY) INs (neurogliaform cells) have been shown to inhibit PN soma and proximal dendrites. (B) Expression of 5-HT receptors in neuron types of the
BLA in rodents. All the IN populations illustrated have been shown to receive somatic and/or dendritic 5-HT innervation (apart from CCK-negative 5-HT3A INs). PV
INs express excitatory, metabotropic 5-HT2A receptors. Thirty percent of SOM INs also seem to express 5-HT2A. Ionotropic, excitatory 5-HT3A receptors are
expressed by a small proportion of CCK INs and a population of INs not expressing any other known marker. NPY INs express either inhibitory, metabotropic 5-HT1A
receptors or excitatory, metabotropic 5-HT2C receptors. In some cases, both receptors could be localized on the same neuron. It is not clear what 5-HT receptor
may be expressed by VIP INs. In the whole BLA, PNs are innervated by 5-HT axons only on dendrites, often on spines. In the lateral amygdala (LA), they appear to
express excitatory 5-HT2C receptors mediating membrane depolarization. Axon terminals of LA PNs innervating basal (BA) PNs might express 5-HT1A and/or
5-HT4 receptors. In the BA, PNs seem to express 5-HT2A receptors on their distal dendrites. These receptors do not lead to depolarization, they might rather favor
synaptic plasticity of excitatory inputs. A proportion of BA PNs might also express inhibitory 5-HT1A receptors, mediating membrane hyperpolarization.
Abbreviations: DRN, dorsal raphe nuclei.
(Bonn et al., 2013). Around 50–60% of NPY+ INs express
5-HT1A, suggesting they might be inhibited by 5-HT, while
30–40% express 5-HT2C, indicating they could be depolarized
(Table 1, Bonn et al., 2013). Modulation of these neurons by
5-HT could be important for aspects of emotionality, because
the activity of NPY cells has been proposed to be anxiolytic
(Truitt et al., 2009). However, their involvement in fear memory
processing is unclear.
In neocortex, prominent inhibition of SOM INs is provided
by vasoactive intestinal peptide (VIP) INs, which promote
disinhibition of pyramidal cells dendrites (Pfeffer et al., 2013). In
the BLA, VIP INs have been shown to target PNs and calbindin
(CB)-expressing INs (Muller et al., 2003). Asmost of BLA PV and
SOM INs co-express CB, their inhibition by VIP INs is likely, but
not yet demonstrated. VIP INs are innervated synaptically and
non-synaptically by 5-HT axons (Muller et al., 2007), but it is
not clear yet which 5-HT receptors they express. In neocortex,
VIP INs are depolarized by 5-HT via ionotropic 5-HT3 receptors
(Férézou et al., 2002), but virtually no VIP IN appears to express
5-HT3 receptors in the BLA (Mascagni and McDonald, 2007).
Together with VIP INs, ‘‘small’’ cholecystokinin (CCK) INs
largely co-express calretinin (CR) in the BLA. In contrast, ‘‘large’’
CCK INs express CB but not VIP. In the HPC, CCK INs are
a central target for 5-HT input and they express ionotropic
5-HT3 receptors (Morales and Bloom, 1997), which mediate
fast synaptic depolarizations (Férézou et al., 2002; Varga et al.,
2009). This seems to be the case in the BLA as well, but only
a minority of large CCK INs could be labeled with a 5-HT3A
antibody (Mascagni and McDonald, 2007). Surprisingly, the
majority of 5-HT3A+ neurons do not belong to any previously
characterized GABAergic population (Table 1, Mascagni and
McDonald, 2007).
As well as postsynaptic innervation, axon terminals
expressing 5-HT form appositions with 5-HT-negative axon
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FIGURE 3 | 5-HT innervation of the mouse amygdala. Green fluorescent protein (GFP) expressed in 5-HTT + DRN neurons via injection of the Cre-dependent
anterograde tracer rAAV2/1.hSynapsin.EGFP.WPRE.bGH in the DRN of SLC6A4-Cre (5-HTT-Cre) mice. This produces a pattern of innervation of the amygdaloid
complex that is similar to the one previously described using antibodies for 5-HT or the 5-HTT. The densest innervation occurs in BA and BLp nuclei. Weaker
innervation is observed in LA, BM and CeA, with the exception of CeC. Abbreviations: BA, basal amygdala; BLp, basolateral amygdala posterior portion; BLv,
basolateral amygdala ventral portion; BM, basomedial amygdala; CeA, central nucleus of the amygdala; CeC, centrocentral amygdala; CeL, centrolateral amygdala;
CeM, centromedial amygdala; LAdl, lateral amygdala dorsolater portion; LAvl, lateral amygdala ventrolateral portion; LAvm, lateral amygdala ventromedial portion;
mITC, main intercalated cell cluster nucleus; AP, antero-posterior (distance from bregma); scale bar: 500 µm. Adapted from: Allen Mouse Brain Connectivity Atlas
(Oh et al., 2014), experiment 114155190. Website: © 2015 Allen Institute for Brain Science. Available from: http://connectivity.brain-map.org.
terminals in the BLA (Muller et al., 2007). This suggests
that 5-HT not only modulates BLA neuron excitability
postsynaptically, but also the release of other neurotransmitters
presynaptically. In agreement with this, pharmacological
experiments performed in acute brain slices show that 5-HT
can modulate glutamate release in the BLA (Cheng et al.,
1998; Huang and Kandel, 2007), suggesting glutamatergic axon
terminals might express 5-HT receptors. Taken together, these
observations demonstrate that DRN 5-HT neurons innervate
both BLA PNs and various types of GABAergic IN populations
synaptically and extra-synaptically, and that 5-HT acts on both
excitatory and inhibitory 5-HT receptors.
5-HT MODULATION OF BLA
INFORMATION PROCESSING
Having explored the complex localization of specific 5-HT
receptors on distinct cell types, we now ask what are the
functional consequences of 5-HT release on BLA circuit
dynamics. To address this issue, we describe data originating
from experiments involving electrophysiological recordings of
BLA neurons and pharmacological activation/inhibition of 5-HT
receptors.
Lateral Amygdala
As previously emphasized, the LA is the main recipient of
somatosensory information within the basolateral complex. The
regulation of fear learning described in the previous sections
could arise from 5-HT modulation of the inputs received by PNs
and/or PN excitability. Perturbing these parameters could affect
PN integration of CS and US information. In vivo recordings
from LA neurons have shown that 5-HT depresses glutamatergic
transmission from auditory cortex and thalamus (Stutzmann
et al., 1998). Ex vivo patch-clamp studies have clarified that
application of 5-HT depresses excitatory postsynaptic currents
(EPSCs) from thalamic afferents in LA PNs via suppression
of glutamate release mediated by 5-HT2 receptors (Yamamoto
et al., 2012). As 5-HT2 receptors located on axon terminals are
generally known to facilitate, and not depress, neurotransmitter
release (Hasuo et al., 2002), this depression could occur via
action of 5-HT on 5-HT2 receptors located on GABAergic
INs (Stutzmann and LeDoux, 1999). At the same time, 5-HT
application increases the excitability of LA PNs via 5-HT2C-
mediated membrane depolarization (Yamamoto et al., 2014).
Hence, 5-HT might bring PNs closer to the threshold for action
potential generation and coincidently provide high-pass filtering
(Abbott and Regehr, 2004) to suppress superfluous excitatory
inputs from somatosensory areas. Together, these mechanisms
might increase the signal-to-noise ratio for strong sensory
stimuli and raise their chances of producing action potentials
in LA PNs. To elucidate the mechanisms leading to altered fear
learning upon 5-HT neurotransmission manipulation in vivo, it
remains to be demonstrated whether 5-HT release modulates the
induction of LTP at US and CS relaying synapses onto LA PNs.
Basal Amygdala: Effects on Excitatory
Transmission
The BA receives strong excitatory glutamatergic inputs from
areas implicated in high-level polymodal sensory processing
and memory, such as the entorhinal cortex (McDonald
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and Mascagni, 1997), HPC (Kishi et al., 2006) and mPFC
(McDonald et al., 1996). Additionally, BA PNs receive excitatory
inputs from LA PNs (Pitkänen et al., 1995). Given that the
innervation of BA by somatosensory areas is minor (LeDoux
et al., 1987; Shi and Cassell, 1998), LA PNs might relay
information about the CS and US to BA neurons (Pitkänen et al.,
1997).
The BA has a high density of 5-HT axons (Sur et al.,
1996). Therefore, 5-HT could modulate the relay of CS and US
information to BA PNs, ultimately shaping freezing responses
via their excitatory output to the CeA. Intracellular recordings
from BA PNs have shown that 5-HT promotes depression
of EPSPs at synapses between LA PNs and BA PNs (Cheng
et al., 1998; Yamamoto et al., 2012). Cheng et al. (1998) found
that presynaptic 5-HT1A receptors mediate this effect, while
Yamamoto et al. (2012) reported that 5-HT2 receptors are
involved. The former finding suggests that 5-HT1A receptors
are located on LA PNs axon terminals that synapse onto BA
PNs and activation of these receptors depresses glutamate release.
In contrast, the latter result points towards an involvement
of GABAergic INs (see below), because presynaptic 5-HT2
receptors are excitatory and known to facilitate glutamate
release (Hasuo et al., 2002). Furthermore, high concentrations
of 5-HT (100–300 µM) caused only a transient depression of
BA field EPSPs evoked by stimulation of the LA; this short-term
depression was followed by LTP mediated by 5-HT4 receptor
activation (Huang and Kandel, 2007). Thus, it needs to be
clarified whether release of endogenous 5-HT produces short-
term depression followed by long-lasting facilitation at LA-BA
synapses, or only the former.
Additionally, theta burst stimulation of the external capsule,
a fiber bundle bordering the BLA laterally, triggers only short
term potentiation of EPSPs evoked in BA PNs from electrical
stimulation of the external capsule (Chen et al., 2003). However,
activation of postsynaptic 5-HT2A receptors promotes induction
of LTP at these synapses via facilitated NMDA function (Chen
et al., 2003). This mechanism could occur via 5-HT2A receptors
detected on PNs distal dendrites (McDonald and Mascagni,
2007).
Thus, release of endogenous 5-HT likely modulates short-
term and long-term synaptic plasticity of excitatory synapses
to BA PNs. As the external capsule contains fibers from many
brain regions, it is important to establish whether 5-HT promotes
LTP at specific pathways (e.g., HPC or mPFC). Furthermore, the
impact of this plasticity for learning still needs to be understood.
Basal Amygdala: Effects on Inhibitory
Transmission
A parallel action of 5-HT in the BA is depolarization of
GABAergic INs via 5-HT2 and 5-HT3 receptors (Rainnie, 1999;
Jiang et al., 2009; Bocchio et al., 2015), resulting in increased
inhibition onto PNs. This effect appears to be driven primarily
by 5-HT2A-mediated depolarization of PV INs (Jiang et al.,
2009; Bocchio et al., 2015), which in turn causes inhibition
of PNs (Rainnie, 1999; Bocchio et al., 2015). When 5-HT is
physiologically released instead of bath applied, PV IN activation
might not lead to prolonged membrane hyperpolarization, but
rather influence the precision and synchrony of PNs firing
(Woodruff and Sah, 2007; Ryan et al., 2012).
It is not known whether 5-HT excites or inhibits SOM INs.
The answer to this question is crucial, because SOM INs control
the integration of excitatory inputs in PN dendrites and their
inhibition promotes fear learning (Wolff et al., 2014). McDonald
and Mascagni (2007) detected 5-HT2A receptor expression on
some SOM INs, which suggests that 5-HT depolarizes these cells.
However, this evidence is not categorical as only one out of three
antibodies labeled ∼30% of SOM INs. Expression of 5-HT1A
and/or 5-HT2C receptors on NPY+ INs, which are virtually
all SOM+ in the rat (McDonald, 1989), was recently described
(Bonn et al., 2013). However, electrophysiological recordings
from identified SOM INs are necessary to test the effects of 5-HT
on this important IN population. Although the innervation of
VIP INs by 5-HT axons has been shown (Muller et al., 2007),
the class of 5-HT receptor(s) expressed and the consequences of
5-HT transmission on these neurons is unclear.
In summary, current knowledge suggests that 5-HT in the
BA enhances the perisomatic inhibition of PNs via excitation of
PV INs. This likely shapes PN spike precision and synchrony
(Woodruff and Sah, 2007; Ryan et al., 2012). However, it is
uncertain whether 5-HT also depolarizes SOM INs, leading to
inhibition of PN distal dendrites. In the absence of direct 5-HT
excitation of SOM INs, 5-HT-mediated depolarization of PV INs
(Wolff et al., 2014) or VIP INs could lead to inhibition of SOM
INs. This would, in turn, cause disinhibition of PN dendrites,
which has been shown to facilitate learning (Wolff et al., 2014).
It is important to note that circuit dynamics have largely been
investigated using bath application or iontophoresis of 5-HT.
It must be verified whether physiological release of 5-HT from
DRN neurons recapitulates these effects, as bath application
of drugs may activate more extrasynaptic receptors and lead
to non-physiological effects (Unal et al., 2015). Additionally,
in a behaving rodent, specific stimuli may selectively activate
subpopulations of DRN 5-HT neurons, which in turn could
target 5-HT release to the LA or the BA, or to specific neuronal
populations within these nuclei.
5-HT MODULATION OF BLA THETA
OSCILLATIONS
Given the prominent role of 5-HT in the recruitment of PV
INs, a GABAergic population thought to synchronize large
numbers of PNs (Courtin et al., 2014; Amilhon et al., 2015), a
pertinent question is whether 5-HT affects neuronal synchrony
in the BLA during fear conditioning. The synchronous activity
of large numbers of neurons can be monitored via local field
potential (LFP) recordings, which reveal oscillatory patterns in
different frequency bands occurring during specific brain states
and behaviors (Buzsáki and Draguhn, 2004). These extracellular
voltage signals arise predominantly from synaptic activity, but
also from action potentials or intrinsic membrane oscillations
occurring synchronously in many neurons (Buzsáki et al., 2012).
Oscillations in the theta frequency range (4–12 Hz) occur
in the BLA in vivo (Paré and Collins, 2000). This rhythmic
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network activity likely originates from synaptic inputs from areas
interconnected with the BLA (such as the HPC or the mPFC;
Pape and Pare, 2010) but also from intrinsic theta resonance
of PN membranes (Paré et al., 1995; Pape and Driesang, 1998).
Synchronized theta oscillations between BLA, mPFC and HPC
increase during fear memory retrieval (Seidenbecher et al., 2003;
Lesting et al., 2011; Likhtik et al., 2014) and consolidation (Popa
et al., 2010). Simultaneous LFP and unit recordings suggest that
theta epochs reflect an enhanced theta rhythmicity of the firing
of BLA neurons (Paré and Collins, 2000). This synchronized
firing is believed to facilitate communication between regions in
response to aversive stimuli (Seidenbecher et al., 2003; Popa et al.,
2010; Lesting et al., 2011). In line with this, BLA neurons fire
phase-locked with hippocampal (Bienvenu et al., 2012; Ma n´ko
et al., 2012) and entorhinal theta (Paré and Gaudreau, 1996).
A positive modulation of fear-driven BLA theta oscillations
by 5-HT is suggested by data from LFP recordings in 5-HTT
mutant mice during fear conditioning. Namely, 5-HTTOE mice,
which exhibit low extracellular 5-HT levels, show attenuated
fear-evoked theta oscillations in the BLA during fear memory
acquisition and expression (Figure 1B; Barkus et al., 2014).
Conversely, 5-HTTKOmice, which have high extracellular 5-HT
concentrations, display enhanced theta synchronization between
the BLA and the mPFC (Narayanan et al., 2011). These studies
indicate that 5-HT levels might positively correlate with BLA
theta power and theta synchrony across the BLA-mPFC-HPC
axis. This view is consistent with the finding that DRN 5-HT
neurons show intrinsic theta rhythmic firing (Kocsis and Vertes,
1992).
In mPFC and HPC, PV INs can play an essential role in
controlling theta oscillations (Courtin et al., 2014; Amilhon
et al., 2015). In the BLA, classes of PV INs fire in phase with
hippocampal theta rhythms (Bienvenu et al., 2012). Importantly,
recruitment of BA PV INs during fear memory retrieval
(measured by c-Fos expression) is reduced in 5-HTTOE mice
(Figure 1C; Bocchio et al., 2015). This deficit might be caused by
a weaker depolarizing action of 5-HT on PV INs (Bocchio et al.,
2015) and may, at least in part, underlie impaired fear learning
in these mice (Barkus et al., 2014; Line et al., 2014; Bocchio
et al., 2015; McHugh et al., 2015; Figure 1). Taken together,
these findings point towards a link between 5-HT and BLA
theta oscillations, plausibly via 5-HT-mediated depolarization
of PV INs and their synchronization of large numbers of
PNs via perisomatic inhibition. Notably, the deficient 5-HT
activation of PV INs in 5-HTTOE mice appears to derive not
only from heightened 5-HTT function, but also from aberrant
5-HT2A signaling (Bocchio et al., 2015). Therefore, it cannot be
ruled out that differential theta rhythmicity in 5-HTTKO and
5-HTTOE mice emerges from alterations in BLA circuits during
development and/or from 5-HT receptor compensatory changes.
Furthermore, changes in theta oscillations could be driven by
altered rhythmic inputs from other structures interconnected
with the BLA, such as the HPC or the mPFC. Hence, temporally
selective and reversible manipulation of 5-HT neurotransmission
should be employed in the future to test whether a causal
link between 5-HT, BLA PV INs, BLA theta oscillations and
fear exists.
CONCLUSIONS AND FUTURE
DIRECTIONS
In summary, whole brain changes in extracellular 5-HT
levels (SSRIs, tryptophan depletion, genetic variations in the
5-HTT) influence the acquisition (and likely the expression)
of cued fear memories. Selective manipulation of BLA 5-HT
neurotransmission with lesions and optogenetics demonstrate
that 5-HT modulation of fear learning could be caused, at least
in part, by actions on BLA neurons. Specifically, 5-HT could
orchestrate the BLA microcircuitry in several ways. First, 5-HT
could shape LTP induction at LA PN synapses and control
the formation of PN ensembles encoding the CS. This could
occur via alterations in glutamatergic transmission from sensory
thalamus and cortex to LA PNs and via PN depolarization.
Second, 5-HT facilitates LTP induction at BA PNs excitatory
synapses from axons in the external capsule. Third, 5-HT could
increase theta oscillations and BA PNs spike synchrony via
recruitment of PV INs. These scenarios need to be validated
with further empirical evidence. We propose that examining
the effects of endogenous 5-HT release on discrete GABAergic
IN classes and subcellular compartments of PNs is key to
comprehend the complex effects of 5-HT on BLA circuits and
fear learning. Notably, accumulating evidence suggests that the
amygdala does not only encode aversion, but more generally
affective significance (Morrison and Salzman, 2010; Gore et al.,
2015; Namburi et al., 2015). Thus, besides aversive learning,
5-HT release in the BLA might influence other behaviors, for
example reward processing.
It is essential to take into consideration that, in parallel
to the putative effects on BLA circuits described above,
midbrain 5-HT neurons could shape defensive responses
through action on other brain regions. For instance, 5-HT
modulates PNs and INs in HPC and mPFC (for review Puig
and Gener, 2015), two regions interacting with the BLA in
fear memory processing. Thus, 5-HT might alter HPC-BLA-
mPFC interplay. Moreover, 5-HT could control fear responses
via a downstream effect on the CeA, as recently CeA 5-HT2A+
neurons have been shown to provide a switch from learned
freezing to innate freezing responses (Isosaka et al., 2015).
However, the physiological actions of 5-HT on defined CeA
cell types and circuit dynamics remain to be thoroughly
investigated.
As previously mentioned, findings from rodent models of
genetically altered 5-HT levels (5-HTTKO and 5-HTTOE)
should be confirmed with reversible, spatially and temporally
precise manipulations. This is because in these animal models
5-HT neurotransmission is altered during gestation, brain
development and early-life experiences. Given the role of
5-HT in neuronal circuit formation (Daubert and Condron,
2010), emotional and physiological alterations could arise from
abnormalities occurring during development (e.g., Gross et al.,
2002), rather than from aberrant 5-HT neurotransmission during
fear acquisition and expression.
At least three outstanding questions remain to be
addressed. First, do DRN 5-HT neurons encode aversive
signals during fear conditioning? Second, what DRN
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physiology is able to drive 5-HT release in the BLA?
Third, does 5-HT release in the BLA promote synaptic
plasticity and facilitate fear learning? Recent advances
in bioengineering allow recording and manipulation of
genetically defined neuron populations with high spatial
and temporal resolution, providing valuable tools to
answer these questions. Unambiguous identification of
DRN 5-HT neurons in behaving mice can be achieved
through Cre-dependent expression of opsins followed by
combined optical stimulation and extracellular recordings,
a method named ‘‘optogenetic tagging’’ (Kvitsiani et al.,
2013; Roux et al., 2014). Alternatively, Cre-dependent
expression of genetically encoded calcium sensors followed
by deep brain imaging using an integrated microscope
equipped with a microendoscope can be employed (Ghosh
et al., 2011; Ziv et al., 2013). These approaches could
provide valuable information on the activity of DRN 5-HT
neurons during the CS and US with millisecond-timescale
precision.
Furthermore, optogenetic excitation of 5-HT axons in the
BLA during fear conditioning might disentangle the effect
of 5-HT release during CS and US presentation. Finally,
optical stimulation of 5-HT axons combined with recordings
from defined BLA neuron populations could reveal the effects
of endogenous 5-HT release on BLA circuit dynamics, and
determine whether these recapitulate the effects obtained in
pharmacological studies. This approach could also demonstrate
whether DRN 5-HT neurons exert their action onto BLA circuits
via co-release of glutamate, as reported in the HPC, ventral
tegmental area and nucleus accumbens (Varga et al., 2009; Liu
et al., 2014).
Answering these questions will advance our knowledge not
only of the biological underpinnings of emotional behavior, but
also of the mechanisms of 5-HT signaling that, presumably,
are implicated in the therapeutic effects of SSRIs. Dissecting
the modulation of limbic circuits by endogenous 5-HT could
ultimately contribute to the design of more specific and effective
treatments for psychiatric disorders in which these circuits are
dysregulated.
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